Viewing Study NCT02562118


Ignite Creation Date: 2025-12-25 @ 5:02 AM
Ignite Modification Date: 2026-01-07 @ 1:44 PM
Study NCT ID: NCT02562118
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-25
First Post: 2015-09-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer
Sponsor: National University Hospital, Singapore
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module